Like database studies, retrospective chart reviews also use real-world data to help you better understand drivers that could influence your drug development and post-approval strategies, meet the requirements of risk management programs, or answer epidemiologic questions.
Through our network of partners, we have access to patient charts in both developed and emerging markets. From physician registries in each country of interest, we select participants based on specific characteristics (e.g., physician specialty, years in practice, caseload, practice setting). Selected physicians then abstract data from their own patients’ charts based upon patient selection criteria developed by the study team.
